(Q91036877)
Statements
Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial (English)
H S Rugo
J L Blum
S Hurvitz
J Ettl
R G W Quek
K-H Lee
A Gonçalves
L Fehrenbacher
R Yerushalmi
L A Mina
M Martin
H Roché
Y-H Im
D Markova
H Bhattacharyya
W Eiermann